FI960749A - Uusi suun kautta nautittava farmaseuttinen aine, joka sisältää keltarauhashormonia ja polyetyleeniglykolia yhdessä kantoaineen kanssa - Google Patents

Uusi suun kautta nautittava farmaseuttinen aine, joka sisältää keltarauhashormonia ja polyetyleeniglykolia yhdessä kantoaineen kanssa Download PDF

Info

Publication number
FI960749A
FI960749A FI960749A FI960749A FI960749A FI 960749 A FI960749 A FI 960749A FI 960749 A FI960749 A FI 960749A FI 960749 A FI960749 A FI 960749A FI 960749 A FI960749 A FI 960749A
Authority
FI
Finland
Prior art keywords
pharmaceutical
carrier
new oral
containing progesterone
glucose together
Prior art date
Application number
FI960749A
Other languages
English (en)
Swedish (sv)
Other versions
FI960749A0 (fi
Inventor
Karen Susanne Gram
Annelise Jensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI960749A publication Critical patent/FI960749A/fi
Publication of FI960749A0 publication Critical patent/FI960749A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
FI960749A 1993-08-20 1996-02-19 Uusi suun kautta nautittava farmaseuttinen aine, joka sisältää keltarauhashormonia ja polyetyleeniglykolia yhdessä kantoaineen kanssa FI960749A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK93950A DK95093D0 (da) 1993-08-20 1993-08-20 Farmaceutisk formulering indeholdende et hormon
PCT/DK1994/000310 WO1995005807A1 (en) 1993-08-20 1994-08-19 A novel pharmaceutical for oral administration comprising progesterone and a polyethylene glycol together with an excipient

Publications (2)

Publication Number Publication Date
FI960749A true FI960749A (fi) 1996-02-19
FI960749A0 FI960749A0 (fi) 1996-02-19

Family

ID=8099329

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960749A FI960749A0 (fi) 1993-08-20 1996-02-19 Uusi suun kautta nautittava farmaseuttinen aine, joka sisältää keltarauhashormonia ja polyetyleeniglykolia yhdessä kantoaineen kanssa

Country Status (17)

Country Link
EP (1) EP0789560A1 (fi)
JP (1) JPH09501682A (fi)
KR (1) KR960703570A (fi)
CN (1) CN1132478A (fi)
AU (1) AU7530594A (fi)
BR (1) BR9407306A (fi)
CA (1) CA2169840A1 (fi)
CZ (1) CZ42596A3 (fi)
DK (1) DK95093D0 (fi)
FI (1) FI960749A0 (fi)
HU (1) HUT74167A (fi)
LT (1) LT4043B (fi)
NO (1) NO960653D0 (fi)
NZ (1) NZ271617A (fi)
PL (1) PL313113A1 (fi)
SK (1) SK19396A3 (fi)
WO (1) WO1995005807A1 (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772617B1 (fr) * 1997-12-19 2001-03-09 Besins Iscovesco Lab Comprime de progesterone et son procede de preparation
FR2775599B1 (fr) * 1998-03-09 2001-08-17 Besins Iscovesco Lab Composition pharmaceutique a base de progesterone naturelle de synthese et d'oestradiol et son procede de preparation
GB2339114B (en) * 1998-06-30 2003-03-05 Ericsson Telefon Ab L M Secure messaging in mobile telephones
IL127129A (en) * 1998-11-18 2004-06-01 Ferring Bv Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared
DK1598069T3 (da) * 1999-08-31 2009-07-06 Bayer Schering Pharma Ag Farmaceutisk præparat af ethinylestradiol og drospirenon til anvendelse som præventionsmiddel
US6544553B1 (en) 1999-12-28 2003-04-08 Watson Pharmaceuticals, Inc. Dosage forms and methods for oral delivery of progesterone
FI20002768A (fi) * 2000-12-18 2002-06-19 Licentia Oy Enteropäällysteisiä lääkekoostumuksia ja niiden valmistus
CA2479295A1 (en) * 2002-03-14 2003-09-25 Thomas C. Ho Progesterone oral drug delivery system
DE602004016311D1 (de) * 2003-04-29 2008-10-16 Organon Nv Verfahren zur verfestigung, bei welchem ein anti-lösungsmittel benutzt wird
WO2007030153A2 (en) 2005-04-28 2007-03-15 Wyeth Compositions containing micronized tanaproget
AT12800U1 (de) * 2007-11-05 2012-11-15 Bayer Schering Pharma Ag Pharmazeutisches Präparat zur Verwendung bei der oralen Kontrazeption von Frauen mit Laktoseintoleranz
US9375437B2 (en) 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
US20110312928A1 (en) * 2010-06-18 2011-12-22 Lipocine Inc. Progesterone Containing Oral Dosage Forms and Related Methods
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
HUE055562T2 (hu) 2011-11-23 2021-11-29 Therapeuticsmd Inc Természetes kombinációjú hormon helyettesítõ kiszerelések, és terápiák ezekkel
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
JP2018522854A (ja) 2015-06-22 2018-08-16 リポカイン インコーポレーテッド １７−ヒドロキシプロゲステロンエステル含有経口組成物及び関連方法
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862311A (en) * 1971-04-12 1975-01-21 Ciba Geigy Corp Novel method of enhancing progestational endometrial proliferation with progesterone
FR2408345A1 (fr) 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
GB2091552A (en) 1980-09-09 1982-08-04 Carnrick G W Ltd Use of progesterone for the treatment of post-menopausal women
US4963540A (en) * 1986-04-16 1990-10-16 Maxson Wayne S Method for treatment of premenstrual syndrome
US5116619A (en) 1988-08-30 1992-05-26 Lee Roy Morgan Vaginal progesterone tablet
US5084277A (en) 1988-08-30 1992-01-28 Greco John C Vaginal progesterone tablet
WO1990008537A1 (en) * 1989-02-06 1990-08-09 Abbott Laboratories Pharmaceutical compositions for oral administration
US5223268A (en) * 1991-05-16 1993-06-29 Sterling Drug, Inc. Low solubility drug-coated bead compositions

Also Published As

Publication number Publication date
NZ271617A (en) 1996-11-26
KR960703570A (ko) 1996-08-31
CZ42596A3 (en) 1996-06-12
LT4043B (en) 1996-09-25
EP0789560A1 (en) 1997-08-20
SK19396A3 (en) 1997-03-05
NO960653L (no) 1996-02-19
DK95093D0 (da) 1993-08-20
PL313113A1 (en) 1996-06-10
WO1995005807A1 (en) 1995-03-02
AU7530594A (en) 1995-03-21
CN1132478A (zh) 1996-10-02
CA2169840A1 (en) 1995-03-02
HU9600376D0 (en) 1996-04-29
LT96010A (fi) 1996-06-25
NO960653D0 (no) 1996-02-19
FI960749A0 (fi) 1996-02-19
JPH09501682A (ja) 1997-02-18
BR9407306A (pt) 1996-10-08
HUT74167A (en) 1996-11-28

Similar Documents

Publication Publication Date Title
FI960749A (fi) Uusi suun kautta nautittava farmaseuttinen aine, joka sisältää keltarauhashormonia ja polyetyleeniglykolia yhdessä kantoaineen kanssa
DK50191A (da) Orale farmaceutiske praeparater med colonselektiv afgivelse
FI943570A0 (fi) 1-bentseenisulfonyyli-1,3-dihydroindol-2-onijohdannaisia, niiden valmistus ja niitä sisältäviä lääkeaineita
FI954098A0 (fi) Kuivajauheen inhalaattorin lääkeaineen kantolaite
DE3688532D1 (de) Pharmazeutische darreichungsform mit verzoegerter abgabe.
FI972646A0 (fi) Piperatsiinijohdannaiset, näitä yhdisteitä sisältävät lääkeaineet, niiden käyttö ja menetelmä niiden valmistamiseksi
FI954115A (fi) Lääkesäiliön suljinlaite
ATA903696A (de) Elektrotransport-medikamentenverabreichung
FI941137A0 (fi) 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi
DE69617431D1 (de) Arzneipulverkartusche mit integrierter dosiereinrichtung, sowie pulverinhalator
DE68901494D1 (de) Zusammensetzungen mit verzoegerten wirkstoffabgaben.
DE3480599D1 (de) 1-hydroxypyrid-2-on-derivate enthaltende pharmazeutische zubereitungen.
KR950700754A (ko) 신규의 약물(novel medicament)
FI103050B1 (fi) Menetelmä N,O-sulfatoituja heparosaaneja sisältävän koostumuksen valmistamiseksi
EE03111B1 (et) Glükokortikosteroidi epimeerid, nende valmistamise protsessid ja neid sisaldavad ravimpreparaadid
HUP9900348A3 (en) New oxazolidinone derivatives, preparation and use thereof and medicaments containing these compounds
ES552145A0 (es) Procedimiento de fabricacion de una unidad de dosificacion para la administracion oral de cloruro potasico.
IL94806A0 (en) Pharmaceutical preparation containing thiol derivatives together with other active compounds
NO982874D0 (no) Farmas°ytiske preparater med vitamin D-analoger
EE04348B1 (et) Sahhariidderivaadid, neid sisaldav farmatseutiline kompositsioon ja nende kasutamine
EE9400070A (et) Bioloogiliselt aktiivsed eburnameniini derivaadid, neid sisaldavad farmatseutilised segud ja nende valmistamise protsess
NO942215D0 (no) Ureaderivat som inneholder en heterocyklisk ring
HUP0101131A2 (hu) Gyulladásgátló hatású dihidrobenzopirán-származékok, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
ATE63215T1 (de) Teilbare kapsel.
FI963683A0 (fi) Dimetikonin käyttö kuljetus- ja kantoainejärjestelmänä ja/tai lääkeaineen jakelujärjestelmä

Legal Events

Date Code Title Description
FD Application lapsed